Seegene Inc (096530) - Net Assets

Latest as of June 2026: ₩1.04 Trillion KRW ≈ $704.41 Million USD

Based on the latest financial reports, Seegene Inc (096530) has net assets worth ₩1.04 Trillion KRW (≈ $704.41 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩1.27 Trillion ≈ $858.01 Million USD) and total liabilities (₩226.66 Billion ≈ $153.60 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Seegene Inc (096530) strategic asset index to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩1.04 Trillion
% of Total Assets	82.1%
Annual Growth Rate	27.79%
5-Year Change	-6.07%
10-Year Change	615.5%
Growth Volatility	86.85

Seegene Inc - Net Assets Trend (2012–2025)

This chart illustrates how Seegene Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Seegene Inc (096530) total market value.

Annual Net Assets for Seegene Inc (2012–2025)

The table below shows the annual net assets of Seegene Inc from 2012 to 2025. Also explore 096530 net assets growth trend to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	₩1.02 Trillion ≈ $688.40 Million	+3.50%
2024-12-31	₩981.48 Billion ≈ $665.13 Million	-4.75%
2023-12-31	₩1.03 Trillion ≈ $698.29 Million	-10.23%
2022-12-31	₩1.15 Trillion ≈ $777.83 Million	+6.14%
2021-12-31	₩1.08 Trillion ≈ $732.85 Million	+67.58%
2020-12-31	₩645.32 Billion ≈ $437.32 Million	+323.02%
2019-12-31	₩152.55 Billion ≈ $103.38 Million	+19.15%
2018-12-31	₩128.03 Billion ≈ $86.76 Million	+2.39%
2017-12-31	₩125.04 Billion ≈ $84.74 Million	-11.93%
2016-12-31	₩141.97 Billion ≈ $96.21 Million	+5.09%
2015-12-31	₩135.09 Billion ≈ $91.55 Million	+42.45%
2014-12-31	₩94.83 Billion ≈ $64.27 Million	+12.30%
2013-12-31	₩84.44 Billion ≈ $57.23 Million	+101.36%
2012-12-31	₩41.94 Billion ≈ $28.42 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Seegene Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2725.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩1.09 Trillion	107.18%
Total Equity	₩1.02 Trillion	100.00%

Seegene Inc Competitors by Market Cap

The table below lists competitors of Seegene Inc ranked by their market capitalization.

Company	Market Cap
Vertex NASDAQ:VERX	$1.00 Billion
Shen Ma Industry Co Ltd SHG:600810	$1.00 Billion
Sigma Lithium Resources Corp NASDAQ:SGML	$1.00 Billion
Altri SGPS SA LS:ALTR	$1.00 Billion
Sumavision Technologies SHE:300079	$1.00 Billion
Compass Minerals International Inc NYSE:CMP	$1.00 Billion
IDI Insurance Company Ltd TA:IDIN	$1.00 Billion
Wah Lee Industrial Corp TW:3010	$1.00 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Seegene Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 978,626,295,130 to 1,015,447,544,130, a change of 36,821,249,000 (3.8%).
Net income of 48,274,770,360 contributed positively to equity growth.
Dividend payments of 36,900,802,200 reduced retained earnings.
Share repurchases of 4,126,946,220 reduced equity.
Other factors increased equity by 29,574,227,060.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩48.27 Billion	+4.75%
Dividends Paid	₩36.90 Billion	-3.63%
Share Repurchases	₩4.13 Billion	-0.41%
Other Changes	₩29.57 Billion	+2.91%
Total Change	₩-	3.76%

Book Value vs Market Value Analysis

This analysis compares Seegene Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.46x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 11.93x to 1.46x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩2720.46	₩32450.00	x
2017-12-31	₩2405.40	₩32450.00	x
2018-12-31	₩2462.83	₩32450.00	x
2019-12-31	₩2934.53	₩32450.00	x
2020-12-31	₩12413.77	₩32450.00	x
2021-12-31	₩20971.05	₩32450.00	x
2022-12-31	₩23036.65	₩32450.00	x
2023-12-31	₩22052.71	₩32450.00	x
2024-12-31	₩21188.30	₩32450.00	x
2025-12-31	₩22290.20	₩32450.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Seegene Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 4.75%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 10.18%
• Asset Turnover: 0.38x
• Equity Multiplier: 1.22x
Recent ROE (4.75%) is below the historical average (16.10%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	9.65%	14.19%	0.47x	1.46x	₩-333.62 Million
2015	5.01%	10.40%	0.34x	1.44x	₩-6.73 Billion
2016	5.02%	9.67%	0.35x	1.46x	₩-7.07 Billion
2017	1.59%	2.29%	0.53x	1.32x	₩-10.52 Billion
2018	8.38%	10.49%	0.62x	1.28x	₩-2.07 Billion
2019	17.48%	21.87%	0.62x	1.28x	₩11.42 Billion
2020	77.83%	44.64%	1.03x	1.70x	₩437.75 Billion
2021	49.62%	39.14%	0.92x	1.38x	₩428.42 Billion
2022	15.87%	21.34%	0.61x	1.21x	₩67.36 Billion
2023	0.07%	0.18%	0.29x	1.22x	₩-102.10 Billion
2024	-2.08%	-4.91%	0.34x	1.23x	₩-118.20 Billion
2025	4.75%	10.18%	0.38x	1.22x	₩-53.27 Billion

Industry Comparison

This section compares Seegene Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $216,421,285,531
Average return on equity (ROE) among peers: 5.45%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Seegene Inc (096530)	₩1.04 Trillion	9.65%	0.22x	$1.00 Billion
ORIENTBIO Inc. (002630)	$83.19 Billion	41.11%	0.26x	$73.37 Million
Green Cross (005250)	$221.73 Billion	2.76%	8.07x	$288.37 Million
Green Cross Holdings Preference Shares (005257)	$1.51 Trillion	0.20%	0.84x	$2.96 Million
Pharmicell (005690)	$86.44 Billion	7.32%	0.15x	$472.92 Million
GeneOne Life Science Inc (011000)	$33.79 Billion	0.00%	0.20x	$32.81 Million
HLB Co. Ltd (028300)	$9.77 Billion	0.00%	1.53x	$2.87 Billion
Mgenplus Co. Ltd. (032790)	$17.38 Billion	0.00%	1.46x	$22.01 Million
Daesung Microbiological Labs. Co. Ltd (036480)	$19.73 Billion	2.26%	0.29x	$15.84 Million
Seoulin Bioscience Co.Ltd (038070)	$74.86 Billion	20.82%	0.82x	$24.11 Million
Hyundai Bioscience Co. Ltd (048410)	$110.73 Billion	-19.98%	0.18x	$445.37 Million

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$1.00 Billion

₩1.48 Trillion KRW

Market Cap Rank

#8903 Global

#231 in Korea

Share Price

₩32450.00

Change (1 day)

+0.62%

52-Week Range

₩21850.00 - ₩35650.00

All Time High

₩140042.88